TherapeuticsMD Inc logo

TXMD - TherapeuticsMD Inc News Story

$0.305 -0.0  -2.7%

Last Trade - 9:00pm

Sector
Healthcare
Size
Small Cap
Market Cap £98.3m
Enterprise Value £158.7m
Revenue £67.0m
Position in Universe 5174th / 7405

BUZZ-TherapeuticsMD: Jumps after UK, Belgium approve hormone therapy

Fri 9th April, 2021 10:40am
** Shares of women's healthcare co  TXMD.O  jump 21.2% to
$1.60 premarket, touching their 50-day moving avg price
    ** TXMD is among most heavily traded stocks across U.S.
exchanges before the bell
    ** Says hormone therapy BIJUVE received regulatory approval
in UK and Belgium  urn:newsml:reuters.com:*:nBwbmDrJQa
    ** Under license agreement with pharma co Theramex, TXMD
will receive a milestone fee for the regulatory approval of drug
in certain European markets, sales milestone fees and royalties
    ** The drug is approved in the U.S. to treat hot flashes due
to menopause in women with a uterus
    ** TXMD has gained 9.1% YTD, as of last close

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))
© Stockopedia 2022, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.